At BRL Medicine Inc., we aim to become the world's leading Cellular & Gene pharmaceutical company in the era of new commercial civilization, with the mission of "Through innovation led by gene editing, develop breakthrough human therapeutics and benefit the whole world". With its independent R&D center and the "Shanghai Research Center for Gene Editing and Cell Therapy", jointly established by BRL Medicine and university, BRL Medicine has obtained more than 100 patent achievements, and initiated 5 Investigator-Initiated clinical Trials (IIT) in 8 leading hospitals in China, with many pipeline projects have entered into IND application stage. Among them, gene editing projects for β-thalassemia, PD1 knockout non-viral targeted integration CAR-T and UCART have achieved excellent clinical results and have published several academic papers in famous academic journals such as Nature Medicine and Nature biotechnology. BRL Medicine has built five technology platforms with independent intellectual property rights, including The Gene Editing Technology Innovation Platform, Hematopoietic Stem Cell Platform, The Quikin CAR-T Platform, Universal Cell Platform and Enhanced T Cell Platforms, and has a 7000 square meter GMP pilot plant and an operating team of more than 200 people, which strongly guarantees the rapid transformation and application of innovative research. BRL Medicine continuously promotes rapid update and iteration of R&D products through patient needs and clinical feedback. Driven by the era of new commercial civilization, BRL Medicine holds an open, shared, and win-win attitude, and works with global innovative biomedical ecological chain companies to accelerate the transformation and implementation of innovative drugs, so as to benefit global patients with genetic diseases and malignant tumors!
Company Details
- Employees
- 11
- Address
- 上海市, 上海市 201109, Cn
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.brlmed.com/
- HQ
- 上海市, 上海市
Brl Medicine 邦耀生物 Questions
Brl Medicine 邦耀生物's website is https://www.brlmed.com/
Brl Medicine 邦耀生物's LinkedIn profile is https://cn.linkedin.com/company/brlmed
Brl Medicine 邦耀生物 has
11 employees.
View email and phone details for 11
employees at Brl Medicine 邦耀生物.
Brl Medicine 邦耀生物's industry is
Pharmaceutical Manufacturing
Brl Medicine 邦耀生物's top competitors are
Genentech,
Jw Therapeutics 药明巨诺,
Juventas Cell Therapy Corp.,
Beam Therapeutics,
Atara Biotherapeutics,
北京清辉联诺生物科技有限责任公司-Unicet Biotech,
Anocca,
Iaso Biotherapeutics（驯鹿生物）,
Sineugene Therapeutics,
Neuexcell Therapeutics.
Brl Medicine 邦耀生物's categories are Pharmaceutical Manufacturing
